Baltimore-The American Foundation for Urologic Disease's Reproductive Health Council has developed a new patient brochure about the benefits and possible risks of testosterone replacement therapy (TRT).
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.